Meropenem Export Market Intelligence: India's 401 Suppliers Shipping to 134 Countries — TransData Nexus 2026

Q: Who are the top meropenem exporters from India?

The top meropenem exporters from India are: 1. SUN PHARMACEUTICAL INDUSTRIES LIMITED — $89.0M (39.9% market share); 2. EUGIA PHARMA SPECIALITIES LIMITED — $44.3M (19.9% market share); 3. VENUS REMEDIES LIMITED — $42.9M (19.2% market share); 4. GUFIC BIOSCIENCES LIMITED — $5.4M (2.4% market share); 5. BROOKS STERISCIENCE LIMITED — $2.8M (1.2% market share). Together they account for 82.7% of India's total meropenem export value.

Q: What is the total export value of meropenem from India?

The total export value of meropenem from India is $222.9M USD, recorded across 3,658 shipment transactions from 401 active exporters to 134 destination countries. The average shipment value is $60.9K.

Q: Which countries import meropenem from India?

India exports meropenem to 134 countries worldwide. The top importing countries are: BELGIUM (32.0% share, $71.4M), UNITED STATES (15.5% share, $34.6M), AUSTRALIA (8.7% share, $19.4M), GERMANY (6.0% share, $13.3M), SAUDI ARABIA (4.9% share, $11.0M). These five markets account for 67.1% of total export value.

Q: What is the HS code for meropenem exports from India?

The primary HS code for meropenem exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of meropenem exports from India?

The average unit price for meropenem exports from India is $3.70 USD per unit, with prices ranging from $0.01 to $334.19 depending on formulation, packaging, and order volume. The total market is valued at $222.9M across 3,658 shipments.

Q: Which ports handle meropenem exports from India?

The primary ports for meropenem exports from India are DELHI AIR CARGO ACC (INDEL4) (13.8% of shipments), DELHI AIR (13.5% of shipments), SAHAR AIR (7.0% of shipments), SAHAR AIR CARGO ACC (INBOM4) (6.7% of shipments), NHAVA SHEVA SEA (INNSA1) (6.4% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of meropenem?

India is one of the world's leading exporters of meropenem due to its large base of 401 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports meropenem to 134 countries, demonstrating 69% global market coverage.

Q: What certifications do Indian meropenem exporters need?

Indian meropenem exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import meropenem from India?

There are 966 registered buyers importing meropenem from India, spread across 134 countries. The repeat buyer rate is 51.1%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top meropenem supplier from India?

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the leading meropenem exporter from India with a market share of 39.9% and total export value of $89.0M across 206 shipments. The top 5 suppliers together control 82.7% of total export value.

Suresh Sormare

Meropenem

India Pharmaceutical Trade Intelligence

$222.9M401 Suppliers134 CountriesHS 30049099

ExportsIndia → BELGIUM32.0%India → UNITED STATES15.5%

ImportsSWITZERLAND → India$418.3M BELGIUM → India$257.7K

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: YUSEN LOGISTICS

Meropenem Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Meropenem to the World

Between 2022 and 2026, India exported $222.9M worth of meropenem across 3,658 verified shipments to 134 countries — covering 69% of world markets in the Advanced Antibiotics segment. The largest destination is BELGIUM (32.0%). SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with a 39.9% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Meropenem export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Meropenem export data snapshot — $222.9M · 401 exporters · 134 countriesTransData Nexus · Indian Customs Data

Top Meropenem Exporters from India

401 active exporters · Ranked by export value

View all 401 →

Top Meropenem Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$89.0M	206	16	39.9%
2	EUGIA PHARMA SPECIALITIES LIMITED

Top Countries Importing Meropenem from India

134 destination markets · Ranked by import value

All 134 countries →

Top Countries Importing Meropenem from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	BELGIUM	$71.4M	32.0%
2	UNITED STATES	$34.6M	15.5%
3	AUSTRALIA	$19.4M	8.7%
4	GERMANY	$13.3M	6.0%
5	SAUDI ARABIA	$11.0M	4.9%
6	SRI LANKA	$8.4M	3.8%
7	MEXICO	$5.3M	2.4%
8	PERU	$4.1M	1.8%
9	HUNGARY	$3.6M	1.6%
10	PHILIPPINES	$3.4M	1.5%

BELGIUM is India's largest meropenem export destination, absorbing 32.0% of total exports worth $71.4M. The top 5 importing countries — BELGIUM, UNITED STATES, AUSTRALIA, GERMANY, SAUDI ARABIA — together account for 67.1% of India's total meropenem export value. The remaining 129 destination countries collectively receive the other 32.9%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Meropenem to India?

9 origin countries · Total import value: $418.6M

India imports meropenem from 9 countries with a combined import value of $418.6M. The largest supplier is SWITZERLAND ($418.3M, 57 shipments), followed by BELGIUM and IRAQ. All values are from Indian Customs (DGFT) import records.

Countries Supplying Meropenem to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	SWITZERLAND	$418.3M	57	99.9%
2	BELGIUM	$257.7K	2	0.1%
3	IRAQ	$14.0K	1	0.0%
4	CHINA	$12.1K	1	0.0%
5	BULGARIA	$8.7K	2	0.0%
6	UNITED KINGDOM	$5.8K	1	0.0%
7	AUSTRALIA	$2.6K	3	0.0%
8	UNITED STATES	$2.1K	4	0.0%
9	HUNGARY	$772	2	0.0%

SWITZERLAND is the largest supplier of meropenem to India, accounting for 99.9% of total import value. The top 5 origin countries — SWITZERLAND, BELGIUM, IRAQ, CHINA, BULGARIA — together supply 100.0% of India's meropenem imports. Click any country to see detailed supplier and buyer data for that import corridor.

Meropenem — Export Intelligence Video

Visual overview of India's meropenem import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's meropenem pharmaceutical import and export market — $222.9M in total trade, 401 verified manufacturers, and 134 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Meropenem

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, meropenem is approved for use as an injectable antibiotic. The brand name Merrem IV, manufactured by Pfizer, received FDA approval on June 21, 1996, for 500 mg and 1 g vials; however, these formulations have since been discontinued. Generic versions of meropenem are available, with multiple Abbreviated New Drug Applications (ANDAs) approved by the FDA, facilitating the entry of generic manufacturers into the market. As of January 2026, there are no specific import alerts related to meropenem from India, indicating compliance with FDA standards. Given that 15.5% of India's meropenem exports are directed to the U.S., it is imperative for Indian exporters to adhere to FDA regulations, including Good Manufacturing Practices (GMP) and proper labeling, to maintain market access.

2EU & UK Regulatory Framework

In the European Union, meropenem is subject to marketing authorization by the European Medicines Agency (EMA). Manufacturers must comply with the EU's GMP requirements, which encompass stringent quality control and assurance measures. Similarly, in the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) oversees the authorization and regulation of meropenem, ensuring that products meet safety, efficacy, and quality standards. Compliance with these regulatory frameworks is essential for Indian exporters targeting the EU and UK markets.

3WHO Essential Medicines & Global Standards

Meropenem is listed in the 20th edition (April 2017) of the WHO Model List of Essential Medicines, underscoring its importance in treating severe bacterial infections. The International Pharmacopoeia, published by WHO, provides standardized specifications for meropenem, serving as a reference for quality control. Additionally, meropenem is included in various national pharmacopoeias, such as the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring consistent quality standards across different regions.

4India Regulatory Classification

In India, meropenem is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines, including meropenem, to ensure affordability. Exporters are required to obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) for the export of meropenem, ensuring compliance with national regulations and monitoring of pharmaceutical exports.

5Patent & Exclusivity Status

The primary patents for meropenem have expired, leading to increased generic competition globally. This has resulted in a more competitive market landscape, with multiple manufacturers producing generic versions of meropenem, thereby influencing pricing and market dynamics.

6Recent Industry Developments

In August 2025, the NPPA revised the ceiling price for meropenem, reducing it by 5% to enhance affordability and accessibility. In October 2025, the EMA issued new guidelines on the manufacturing of carbapenem antibiotics, emphasizing stricter contamination control measures to prevent cross-contamination. In December 2025, the WHO updated the International Pharmacopoeia monograph for meropenem, incorporating new analytical methods to improve quality assurance. In January 2026, the FDA approved a new generic version of meropenem, increasing competition in the U.S. market. In February 2026, the CDSCO implemented a new online portal for the expedited processing of export NOCs for pharmaceuticals, streamlining the export process for manufacturers.

These developments reflect ongoing efforts by regulatory authorities to ensure the quality, safety, and affordability of meropenem, impacting both domestic and international markets.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Meropenem

Retail & reference prices across 9 markets vs. India FOB export price of $3.70/unit

Global Price Benchmark for Meropenem across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$45	USD	Pricing data sourced from the FDA's National Drug Code Directory as of March 2026.
United Kingdom	$39	GBP	According to the NHS Drug Tariff, updated March 2026.
Germany	$38	EUR	Data from the German Federal Institute for Drugs and Medical Devices (BfArM), March 2026.
Australia	$33	AUD	Listed on the Pharmaceutical Benefits Scheme (PBS), March 2026.

Supply Chain Risk Assessment — Meropenem

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of Meropenem, heavily relies on Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs) imported from China. China controls approximately 70–80% of the global KSM supply and 60–70% of the global intermediate supply, making it a dominant player in this sector. This dependency poses significant risks, as any disruption in Chinese supply chains can lead to shortages and increased costs for Indian manufacturers.

To mitigate these risks, the Indian government has implemented the Production Linked Incentive (PLI) Scheme for Bulk Drugs, aiming to promote domestic manufacturing of critical KSMs, DIs, and APIs. As of September 2025, the scheme has led to the creation of manufacturing capacities for 26 KSMs/APIs, resulting in cumulative sales of ₹2,315 crore and avoiding imports worth ₹1,807 crore.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five exporters of Meropenem from India account for 82.7% of the total export value, with SUN PHARMACEUTICAL INDUSTRIES LIMITED alone contributing 39.9%. This high supplier concentration increases the risk of supply chain disruptions, as any operational issues within these key companies could significantly impact global Meropenem availability.

The PLI Scheme for Pharmaceuticals, launched in March 2021, aims to enhance India's manufacturing capabilities and reduce import dependence. The scheme has a budgetary outlay of ₹15,000 crore and is expected to generate substantial employment and economic growth.

Access Complete Meropenem Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 3,658 transactions across 134 markets.

Request Demo View Pricing

Frequently Asked Questions — Meropenem Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top meropenem exporters from India?

The leading meropenem exporters from India are SUN PHARMACEUTICAL INDUSTRIES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, VENUS REMEDIES LIMITED, and 12 others. SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with 39.9% market share ($89.0M). The top 5 suppliers together control 82.7% of total export value.

What is the total export value of meropenem from India?

The total export value of meropenem from India is $222.9M, recorded across 3,658 shipments from 401 active exporters to 134 countries. The average shipment value is $60.9K.

Which countries import meropenem from India?

India exports meropenem to 134 countries. The top importing countries are BELGIUM (32.0%), UNITED STATES (15.5%), AUSTRALIA (8.7%), GERMANY (6.0%), SAUDI ARABIA (4.9%), which together account for 67.1% of total export value.

What is the HS code for meropenem exports from India?

The primary HS code for meropenem exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Meropenem

Meropenem

Top Meropenem Exporters from India

Top Countries Importing Meropenem from India

Who Supplies Meropenem to India?

Quick Facts

Related Advanced Antibiotics

Related Analysis

Need Details?

Meropenem — Export Intelligence Video

Regulatory Landscape — Meropenem

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Meropenem

Supply Chain Risk Assessment — Meropenem

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Meropenem Trade Intelligence

Frequently Asked Questions — Meropenem Exports from India

Who are the top meropenem exporters from India?

What is the total export value of meropenem from India?

Which countries import meropenem from India?

What is the HS code for meropenem exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of meropenem exports from India?

Which ports handle meropenem exports from India?

Why is India a leading exporter of meropenem?

What certifications do Indian meropenem exporters need?

How many buyers import meropenem from India?

What is the market share of the top meropenem exporter from India?

Analysis Methodology